Regulations.gov document
Reference 4--Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products…
Supporting & Related Material · FDA-2021-N-1333 · posted Jun 18, 2024
Key facts
| Document ID | FDA-2021-N-1333-0029 |
|---|---|
| Title | Reference 4--Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2021-N-1333 |
| Posted | Jun 18, 2024 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: